Can Fite BioPharma Ltd (CANF)

[murocman]

Only thing I can think of is:

1. They want something they can have full control over, and a topical formulation might have broader appeal and maybe be available OTC?

It does seem very odd and quite presumptuous unless they know the results of the phase III, in which case they are obligated to report them.

It sure has the appearance of the “cart being in front of the horse”

Murocman